The product is called Narcan and is manufactured by Adapt Pharma. The drug contained in the medication is naloxone, which, when injected through the nose or administered intravenously, can reverse opioid overdoses by blocking receptors in the central nervous system.
“This device will equip those in our communities — families, friends, caregivers and school nurses — with a tool they can rely on without need for medical training or expertise,” said Mike Kelly, president of U.S. operations at Adapt Pharma, in a statement, according to ABC News.
Combating the opioid crisis has become a priority for many in the federal government in recent months. For example, the Senate passed a drug addiction bill, the Food and Drug Administration announced new warning requirements for opioid medication labels and the Obama administration announced actions to combat the epidemic.
More articles on opioids:
Study: 32% of opioid prescriptions are abused in the US
Mass General: Addicts take opioids on hospital campus for quick intervention in case of OD
Baltimore Health Commissioner: One-third of opioid-related deaths due to fatal drug combination
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
